Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no user-facing study details or sections appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-18T00:39:13.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Locations section updated with an expanded list of sites across numerous states and countries; older location blocks were removed and the revision is v3.3.3.
    Difference
    2%
    Check dated 2025-12-20T19:19:16.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-28T01:43:43.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Publications section now states that publications are provided voluntarily by the person who enters information about the study and are about the results of the study. The revision tag was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-20T23:09:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Removed the banner about potential delays due to government funding for the NIH Clinical Center; this is a non-substantive site maintenance update that does not impact the trial information.
    Difference
    0.2%
    Check dated 2025-11-13T17:10:53.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    No core study content changed; only non-substantive formatting and layout updates were applied. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:47:48.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.